Year: 2026

Not for distribution to U.S. newswire services or dissemination in the United States. TORONTO, May 04, 2026 (GLOBE NEWSWIRE) — Flagship Communities Real Estate Investment Trust (“Flagship” or the “REIT”) (TSX: MHC.U; MHC.UN) today released its first quarter 2026 results. The financial results of the REIT have been prepared in accordance with International Accounting Standard 34 (“IAS 34”) as issued by the International Accounting Standards Board (“IASB”). Results are shown in U.S. dollars, unless otherwise noted. First Quarter 2026 ResultsCompared to First Quarter 2025 ResultsRental revenue and related income was $29.9 million, an increase of 20.6% compared to $24.8 million Same Community Revenue1 was $26.9 million, up 8.6% compared to $24.8 million Net income and comprehensive income was $22.1 million compared to $10.5 million Net...

(all amounts in US dollars, unless otherwise noted) VANCOUVER, British Columbia, May 04, 2026 (GLOBE NEWSWIRE) — Ero Copper Corp. (TSX: ERO, NYSE: ERO) (“Ero” or the “Company”) is pleased to announce its operating and financial results for the three months ended March 31, 2026. Management will host a conference call tomorrow, Tuesday, May 5, 2026, at 11:30 a.m. Eastern time to discuss the results. Dial-in details for the call can be found near the end of this press release. HIGHLIGHTSConsolidated Q1 copper production totaled 17,287 tonnes in concentrate at C1 cash costs(1) of $2.39 per pound produced. Quarterly gold production was 5,495 ounces at C1 cash costs(1) and All-in Sustaining Costs (“AISC”)(1) of $2,120 and $4,441 per ounce, respectively. Gold sales in the period totaled 10,330 ounces, including 4,311 ounces...

ZUG, Switzerland and BOSTON, May 04, 2026 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the first quarter ended March 31, 2026. “The first quarter reflected continued execution across CRISPR Therapeutics’ platform,” said Samarth Kulkarni, Ph.D., Chairman and Chief Executive Officer of CRISPR Therapeutics. “We expanded zugo-cel into new autoimmune indications and advanced multiple in vivo liver-directed programs toward the clinic, while CASGEVY continued its momentum. With a strengthened balance sheet and multiple upcoming milestones, we believe 2026 will be a defining year for CRISPR Therapeutics.” Recent Highlights and Outlook Hemoglobinopathies and CASGEVY® (exagamglogene autotemcel)CASGEVY is approved in the U.S., Canada, the U.K., the EU, Switzerland, the Kingdom of Saudi...

HAMPTON, N.H., May 04, 2026 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) today announced Net Income of $33.2 million, or $1.85 in Earnings Per Share (EPS) for the first quarter of 2026, an increase of $5.7 million in Net Income, or $0.16 in EPS, compared to the first quarter of 2025. The Company’s Adjusted Net Income (a non-GAAP financial measure1), which excluded transaction-related costs in connection with the acquisitions of Bangor Natural Gas Company (Bangor), Maine Natural Gas Company (Maine Natural) and Aquarion Water Company of Massachusetts, Inc., Aquarion Water Company of New Hampshire, Inc., and Abenaki Water Co., Inc. (the Aquarion Companies), was $33.8 million, or $1.88 in EPS, for the first quarter of 2026, an increase of $5.4 million, or $0.14 in EPS, compared to the first quarter of 2025. “This...

NEW YORK, May 04, 2026 (GLOBE NEWSWIRE) — Vornado Realty Trust (NYSE: VNO) reported today: Quarter Ended March 31, 2026 Financial Results NET LOSS attributable to common shareholders for the quarter ended March 31, 2026 was $22,842,000, or $0.12 per diluted share, compared to net income attributable to common shareholders of $86,842,000, or $0.43 per diluted share, for the prior year’s quarter. FUNDS FROM OPERATIONS (“FFO”) attributable to common shareholders plus assumed conversions (non-GAAP) for the quarter ended March 31, 2026 was $96,263,000, or $0.49 per diluted share, compared to $135,039,000, or $0.67 per diluted share, for the prior year’s quarter. Adjusting for the items that impact period-to-period comparability listed in the table below, FFO attributable to common shareholders plus assumed conversions,...

HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) — Powell Industries, Inc. (NASDAQ: POWL) (“Powell” or the “Company”), a leading supplier of custom-engineered solutions for the management, control and distribution of electrical energy, today announced results for the second quarter Fiscal 2026 ended March 31, 2026. All comparisons are to the second quarter of Fiscal 2025, unless otherwise noted. Key Highlights:Revenues of $297 million increased 6%; Gross profit of $88 million, or 29.6% of revenue, increased 5%; Net income of $45.9 million, or $1.25 per diluted share(1), declined 1%; New orders(2) totaled $490 million, an increase of 97%; Backlog(3) as of March 31, 2026 totaled $1.8 billion, an increase of 33%; Cash and short-term investments as of March 31, 2026 totaled $545 million; Subsequent to quarter end, Powell was awarded a mega(4)...